As per the deal, Tosoh will have the exclusive right to sell Chemtura's Emerald Innovation 1000 flame retardant products to Japanese customers
The brownfield, hydrogen-based project is scheduled for mechanical completion and start-up in early 2019
Divestment was part of Chembond's strategy to invest in other businesses such as water treatment, construction chemicals, industrial coatings, animal nutrition and enzymes
The Cabinet also gave its nod for the revival of closed urea unit of Fertilizer Corporation India Limited (FCIL) at Sindri (Jharkhand) with an investment of Rs 6,000 crore
With CPCB planning to implement odour emission norms, the company sees increase in demand for odour evaluation & management in the country
The company plan to expand the capacity from the current 50000 tonnes per annum (tpa) to 1,50,000 tpa over the next five years
Iron oxides pigments are widely used in paints, coatings and coloured concretes
Shell has received a binding offer of Euro 464 million ($529 million) from DCC Energy for this deal
However, FTAs and inverted duty structure having a negative impact on the industry, which is still witnessing two-thirds of construction chemicals being imported into the country
The company will spend Rs 185 to set up a facility, which will house these units, in Dahej SEZ
The company will acquire a generic pharmaceutical business in Australia together with certain branded pharmaceutical assets from South African firm Aspen Pharmacare Holdings
The company has doubled its production capacity for Visiomer MAAH - an important building block in the production of specialty methacrylates - at its site in Worms (Germany)
Increasing construction spending coupled with positive outlook on automotive industry particularly in China, India, etc is expected to drive the market, as per Grand View Research report
As per the pact, Ascend becomes the strategic supplier to DSM for PA66 base-polymer, while DSM will distribute Ascend's portfolio of PA66 compounds
The new facility, which will focus on filling and packaging of protein therapeutics, will supply medicines for clinical trial programmes of AstraZeneca and MedImmune
The combination will create a specialty pharmaceutical company with one of industry's fastest growing generics businesses
Under 'Make in India', biotechnology to grow to $ 100 billion by 2025, says Dr Harsh Vardhan
Johann Schneider Ammann, Swiss economic affairs minister, urges Indian government to remove the difficulties faced by pharma companies in testing and marketing facilities
India offers huge market for chemical companies. But, to achieve the goals of 'Make in India' initiative, the government has to create favourable conditions for global and local firms to invest in man
The company is setting up the project, with a capital outlay of around Rs 1,200 crores, for manufacturing 200,000 MTPA of phenol and 120,000 MTPA of acetone (a co-product)